ALX Oncology Holdings Inc (ALXO)
1.515
+0.02
(+1.68%)
USD |
NASDAQ |
Nov 05, 16:00
1.53
+0.02
(+0.99%)
After-Hours: 19:07
ALX Oncology Holdings Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2020 | 0.527M |
March 31, 2020 | 0.655M |
December 31, 2019 | 1.213M |
Date | Value |
---|---|
September 30, 2019 | 1.256M |
June 30, 2019 | 1.295M |
March 31, 2019 | 1.032M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.527M
Minimum
Jun 2020
1.213M
Maximum
Dec 2019
0.7983M
Average
0.655M
Median
Mar 2020
Revenue (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 745.74M |
Neurocrine Biosciences Inc | 622.10M |
Eton Pharmaceuticals Inc | 9.074M |
Verve Therapeutics Inc | 6.692M |
Immuneering Corp | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -39.40M |
Total Expenses (Quarterly) | 41.52M |
EPS Diluted (Quarterly) | -0.76 |
Enterprise Value | -68.47M |
Earnings Yield | -239.6% |
Normalized Earnings Yield | -69.44 |